<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9431">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05697978</url>
  </required_header>
  <id_info>
    <org_study_id>CZ-001</org_study_id>
    <nct_id>NCT05697978</nct_id>
  </id_info>
  <brief_title>Distance and Intermediate Visual Acuity in Patients With Implanted Monofocal Negative Aspheric Intraocular Lens</brief_title>
  <acronym>CLAINT</acronym>
  <official_title>Distance and Intermediate Visual Acuity in Patients With Implanted Monofocal Negative Aspheric Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Faculty Hospital Kralovske Vinohrady</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oƒçni centrum Praha a.s.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Somich, s.r.o.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Faculty Hospital Kralovske Vinohrady</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To get the visual outcomes for distance and intermediate and binocular defocus curve in&#xD;
      patients with implanted monofocal intraocular lens Clareon (IOL; model SY60CL; Alcon Vision&#xD;
      LLC) at 3 months after the surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of refractive cataract surgery is to remove the opacity, or cataract and to produce&#xD;
      the desired refractive outcome. In most cases, the desired outcome is an emmetropic eye, or&#xD;
      an eye that sees 20/20 Snellen for distance vision post-surgery with the implant of a&#xD;
      monofocal IOL. This, however, does not offer much in the way of intermediate and near vision.&#xD;
      The increased desire for simultaneous distance, intermediate and near vision has increased&#xD;
      the popularity of multifocal IOLs (MIOLs). However MIOLs provide visual acuity for all&#xD;
      distances, they has occurence of optical phenomena such as glare and halo and lower contrast&#xD;
      sensitivity. Extended depth of focus (EDOF) lens should provide distance vision as good as&#xD;
      monofocal lens and intermediate vision better than monofocal but without or with less&#xD;
      appearance of optical phenomenon or decreased contrast sensitivity.&#xD;
&#xD;
      This study is prospective, multi-center, conducted from 10/2022 to 08/2023 in the&#xD;
      Ophthalmology department of Faculty Hospital Kralovske Vinohrady in Prague, in Eye Center&#xD;
      Prague and Eye Clinic SOMICH (Karlovy Vary). The research protocol was explained to all&#xD;
      participants and informed consent was signed before enrolling patient to the study. The study&#xD;
      was approved by the Ethics Committee of Faculty Hospital Kralovske Vinohrady and will&#xD;
      enrolled up to 100 patients with presence of cataract in both eyes.&#xD;
&#xD;
      Bilateral clear corneal phacoemulsification and IOL implantation is performed by two&#xD;
      experienced surgeon using the same technique in both eyes. The surgical process involved&#xD;
      topical anesthesia, superior 3-step clear corneal incision (2,2mm), 5,0mm curvilinear&#xD;
      capsulorhexis, phacoemulsification, bilateral irrigation- aspiration and implantation of&#xD;
      monofocal aspheric intraocular lens (Clareon Alcon vision LLC).&#xD;
&#xD;
      Patients are scheduled for visit at 3 months after the surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2022</start_date>
  <completion_date type="Anticipated">August 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>each patient in group received monofocal intraocular lens in both eyes</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>no masking</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Monocular corrected Distance Visual Acuity (CDVA)</measure>
    <time_frame>3 months</time_frame>
    <description>Monocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Binocular corrected Distance Visual Acuity (CDVA)</measure>
    <time_frame>3 months</time_frame>
    <description>Binocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Monocular uncorrected intermediate visual acuity (UIVA)</measure>
    <time_frame>3 months</time_frame>
    <description>Monocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Binocular uncorrected intermediate visual acuity (UIVA)</measure>
    <time_frame>3 months</time_frame>
    <description>Binocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Monocular distance corrected intermediate visual acuity (DCIVA)</measure>
    <time_frame>3 months</time_frame>
    <description>Monocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Binocular distance corrected intermediate visual acuity (DCIVA)</measure>
    <time_frame>3 months</time_frame>
    <description>Binocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Binocular defocus curve</measure>
    <time_frame>3 months</time_frame>
    <description>A defocus curve that measures visual acuity should be obtained by using the best corrected distance refraction and then defocusing the image in 0.5 increments from +1.5 to -3.0 diopter with spherical plus and spherical minus trial lenses (i.e.,+1.5 D, +1.0 D, +0.5 D, 0.00 D, -0.5 D, -1.00 D, . . . ,-2.50 D) with visual acuity recorded at each change in correction.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Intraocular Lens</condition>
  <arm_group>
    <arm_group_label>Monofocal lens</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Eyes of patients with implanted monofocal aspheric lens Clareon (Alcon LLC)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Monofocal intraocular lens Clareon (Alcon LLC)</intervention_name>
    <description>monofocal aspheric lens implanted in eyes of patient during routine cataract surgery</description>
    <arm_group_label>Monofocal lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  presence of cataract in both eyes&#xD;
&#xD;
          -  no other ocular pathology affecting visual acuity&#xD;
&#xD;
          -  bilateral phacoemulsification cataract surgery was arranged for both eyes&#xD;
&#xD;
          -  corneal astigmatism up to 0,5 cylinder (measured by IOL Master biometry)&#xD;
&#xD;
          -  dioptric power of both selective lens within 1,5 D range in one patient&#xD;
&#xD;
          -  selecting IOL power between 15 D and 28 D power range&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  complicated cataract&#xD;
&#xD;
          -  corneal opacities or irregularities&#xD;
&#xD;
          -  amblyopia&#xD;
&#xD;
          -  anisometropia&#xD;
&#xD;
          -  coexisting ocular pathologies&#xD;
&#xD;
          -  glaucoma&#xD;
&#xD;
          -  history of ocular surgery&#xD;
&#xD;
          -  refusal or unable to maintain follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Janekova, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eye Center Prague</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Janekova, MD</last_name>
    <phone>+420775727002</phone>
    <email>janekovaandrea@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pavel Studeny, MD</last_name>
    <phone>+420775555342</phone>
    <email>StudenyPavel@seznam.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Eye Center Prague</name>
      <address>
        <city>Prague</city>
        <state>Czech Republic</state>
        <zip>11000</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Janekova, MD</last_name>
      <phone>+420775727002</phone>
      <email>janekovaandrea@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Faculty hospital Kralovske Vinohrady</name>
      <address>
        <city>Prague</city>
        <state>Czech Republic</state>
        <zip>11000</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Janekova, MD</last_name>
      <phone>+420775727002</phone>
      <email>janekovaandrea@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Somich Eye Clinic</name>
      <address>
        <city>Karlovy Vary</city>
        <zip>36001</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pavel Studeny, MD</last_name>
      <phone>775555342</phone>
      <email>StudenyPavel@seznam.cz</email>
    </contact>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <results_reference>
    <citation>Lehmann R, Maxwell A, Lubeck DM, Fong R, Walters TR, Fakadej A. Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large Sample. Clin Ophthalmol. 2021 Apr 20;15:1647-1657. doi: 10.2147/OPTH.S295008. eCollection 2021.</citation>
    <PMID>33907378</PMID>
  </results_reference>
  <results_reference>
    <citation>Werner L, Thatthamla I, Ong M, Schatz H, Garcia-Gonzalez M, Gros-Otero J, Canones-Zafra R, Teus MA. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019 Oct;45(10):1490-1497. doi: 10.1016/j.jcrs.2019.05.017. Epub 2019 Aug 6.</citation>
    <PMID>31399323</PMID>
  </results_reference>
  <results_reference>
    <citation>Bala C, Poyales F, Guarro M, Mesa RR, Mearza A, Varma DK, Jasti S, Lemp-Hull J. Multicountry clinical outcomes of a new nondiffractive presbyopia-correcting IOL. J Cataract Refract Surg. 2022 Feb 1;48(2):136-143. doi: 10.1097/j.jcrs.0000000000000712.</citation>
    <PMID>34288635</PMID>
  </results_reference>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>January 15, 2023</study_first_submitted>
  <study_first_submitted_qc>January 15, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2023</study_first_posted>
  <last_update_submitted>February 21, 2023</last_update_submitted>
  <last_update_submitted_qc>February 21, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Faculty Hospital Kralovske Vinohrady</investigator_affiliation>
    <investigator_full_name>Andrea Janekova</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>intraocular lens</keyword>
  <keyword>monofocal lens</keyword>
  <keyword>intermediate visual acuity</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

